arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Mosaic ImmunoEngineering Inc.

CPMV

— Price unavailable

17 Visible periods

20 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Neutral

auto_awesome

Analytical Summary

Mosaic ImmunoEngineering Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap —

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC 8.3% ↘

FCF / Share $-0.02 ↗

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close.

17-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-687.85K

↑ +25.4% —

FCF / Share Free cash flow per share

$-0.02

↑ +53.8% —

Health Breakdown

Returns ↓

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 May 31, 2020 10-K ↗	FY 2018 May 31, 2019 10-K ↗	FY 2017 May 31, 2018 10-K ↗	FY 2016 May 31, 2017 10-K ↗	FY 2015 May 31, 2016 10-K ↗	FY 2014 May 31, 2015 10-K ↗	FY 2013 May 31, 2014 10-K ↗	FY 2012 May 31, 2013 10-K ↗	FY 2011 May 31, 2012 10-K ↗	FY 2010 May 31, 2011 10-K ↗	FY 2009 May 31, 2010 10-K ↗
EPS Growth YoY (%)	23.1% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	7.1% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	57.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	40.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	25.4% Excellent ↓ Excellent Declining Year-over-year change in net income	8.6% Fair ↓ Fair Declining Year-over-year change in net income	57.7% Excellent Excellent Year-over-year change in net income	35.4% Excellent Excellent Year-over-year change in net income	—	—	-32.8% Weak ↑ Weak Improving Year-over-year change in net income	34.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-2565.9% Weak ↓ Weak Declining Year-over-year change in net income	96.4% Excellent ↑ Excellent Improving Year-over-year change in net income	17.6% Good Good Year-over-year change in net income	-4.9% Weak Weak Year-over-year change in net income	N/M	N/M	58.1% Excellent Excellent Year-over-year change in net income	—	—
FCF Growth YoY (%)	53.8% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	51.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	27.9% Excellent Excellent Year-over-year change in free cash flow	5.7% Fair Fair Year-over-year change in free cash flow	—	—	-29.7% Weak ↓ Weak Declining Year-over-year change in free cash flow	13.7% Fair ↑ Fair Improving Year-over-year change in free cash flow	32.9% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	16.8% Good ↑ Good Improving Year-over-year change in free cash flow	-17.2% Weak ↓ Weak Declining Year-over-year change in free cash flow	9.9% Fair ↑ Fair Improving Year-over-year change in free cash flow	-49.0% Weak Weak Year-over-year change in free cash flow	57.8% Excellent Excellent Year-over-year change in free cash flow	—	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 May 31, 2020 10-K ↗	FY 2018 May 31, 2019 10-K ↗	FY 2017 May 31, 2018 10-K ↗	FY 2016 May 31, 2017 10-K ↗	FY 2015 May 31, 2016 10-K ↗	FY 2014 May 31, 2015 10-K ↗	FY 2013 May 31, 2014 10-K ↗	FY 2012 May 31, 2013 10-K ↗	FY 2011 May 31, 2012 10-K ↗	FY 2010 May 31, 2011 10-K ↗	FY 2009 May 31, 2010 10-K ↗
Effective Tax Rate (%) (%)	-0.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.16x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.26x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.49x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.29x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.18x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.93x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	28.95x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.25x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	-0.92x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.50x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.38x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 May 31, 2020 10-K ↗	FY 2018 May 31, 2019 10-K ↗	FY 2017 May 31, 2018 10-K ↗	FY 2016 May 31, 2017 10-K ↗	FY 2015 May 31, 2016 10-K ↗	FY 2014 May 31, 2015 10-K ↗	FY 2013 May 31, 2014 10-K ↗	FY 2012 May 31, 2013 10-K ↗	FY 2011 May 31, 2012 10-K ↗	FY 2010 May 31, 2011 10-K ↗	FY 2009 May 31, 2010 10-K ↗
Return on Invested Capital (%)	8.3% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	13.0% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	23.9% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	53.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	125.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—
Return on Capital (%) (%)	-3098.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-621.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-779.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-1005.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-1299.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	9.2% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-39%)	13.6% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-9%)	17.2% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+14%)	48.7% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+225%)	131.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+778%)	—	-166.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1212%)	-47.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-414%)	-48.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-423%)	-1.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-108%)	-33.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-325%)	-30.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-304%)	-22.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-250%)	13.5% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-10%)	-68.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-553%)	-95.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-739%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 May 31, 2020 10-K ↗	FY 2018 May 31, 2019 10-K ↗	FY 2017 May 31, 2018 10-K ↗	FY 2016 May 31, 2017 10-K ↗	FY 2015 May 31, 2016 10-K ↗	FY 2014 May 31, 2015 10-K ↗	FY 2013 May 31, 2014 10-K ↗	FY 2012 May 31, 2013 10-K ↗	FY 2011 May 31, 2012 10-K ↗	FY 2010 May 31, 2011 10-K ↗	FY 2009 May 31, 2010 10-K ↗
Interest Coverage (x)	-61.61x Weak Weak Operating income divided by interest expense Optimal: > 5x	-126.50x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-3.62K	$-115.02K	$-156.18K	$-220.65K	$-226.14K	$-352.74K	$-571.92K	$-787.09K	$-2.30M	$-979.64K	$-1.16M	$-2.68M	$-4.72M	$-7.57M	$-4.70M	$-8.45M	—

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 May 31, 2020 10-K ↗	FY 2018 May 31, 2019 10-K ↗	FY 2017 May 31, 2018 10-K ↗	FY 2016 May 31, 2017 10-K ↗	FY 2015 May 31, 2016 10-K ↗	FY 2014 May 31, 2015 10-K ↗	FY 2013 May 31, 2014 10-K ↗	FY 2012 May 31, 2013 10-K ↗	FY 2011 May 31, 2012 10-K ↗	FY 2010 May 31, 2011 10-K ↗	FY 2009 May 31, 2010 10-K ↗
Basic EPS, GAAP (USD)	$-0.10	$-0.13	$-0.14	$-0.33	$-0.55	—	$0.00	$0.00	$0.00	$0.00	$0.00	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.02	$-0.03	$-0.07	$-0.10	$-0.10	—	$-0.00	$-0.00	$-0.00	$-0.00	$-0.00	$-0.00	$-0.00	$-0.00	$-0.01	—	—
Book Value per Share (USD)	$-1.03	$-0.94	$-0.81	$-0.67	$-0.39	$-0.52	$0.00	$0.00	$0.01	$0.01	$0.01	$0.01	$0.02	$0.02	$0.02	$0.03	—
Tangible Book Value per Share (USD)	$-1.03	$-0.94	$-0.81	$-0.67	$-0.39	$-0.52	$0.00	$0.00	$0.01	$0.01	$0.01	$0.01	$0.02	$0.02	$0.02	$0.03	—
Basic Weighted Avg Shares (shares)	7.24M	7.24M	7.24M	7.24M	6.71M	—	398.55M	398.55M	398.55M	398.55M	398.55M	398.55M	401.45M	402.52M	403.63M	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 May 31, 2020 10-K ↗	FY 2018 May 31, 2019 10-K ↗	FY 2017 May 31, 2018 10-K ↗	FY 2016 May 31, 2017 10-K ↗	FY 2015 May 31, 2016 10-K ↗	FY 2014 May 31, 2015 10-K ↗	FY 2013 May 31, 2014 10-K ↗	FY 2012 May 31, 2013 10-K ↗	FY 2011 May 31, 2012 10-K ↗	FY 2010 May 31, 2011 10-K ↗	FY 2009 May 31, 2010 10-K ↗
Working Capital (USD)	$-6.01M	$-5.40M	$-4.55M	$-3.66M	$-2.06M	$-422.54K	$602.81K	$1.54M	$2.24M	$3.26M	$3.08M	$5.08M	$6.41M	$7.76M	$7.55M	$11.62M	—
Total Equity (USD)	$-7.48M	$-6.79M	$-5.87M	$-4.88M	$-2.80M	$-422.54K	$636.02K	$1.70M	$2.50M	$3.70M	$3.75M	$5.02M	$6.51M	$8.14M	$7.09M	$12.02M	$23.35M

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 May 31, 2020 10-K ↗	FY 2018 May 31, 2019 10-K ↗	FY 2017 May 31, 2018 10-K ↗	FY 2016 May 31, 2017 10-K ↗	FY 2015 May 31, 2016 10-K ↗	FY 2014 May 31, 2015 10-K ↗	FY 2013 May 31, 2014 10-K ↗	FY 2012 May 31, 2013 10-K ↗	FY 2011 May 31, 2012 10-K ↗	FY 2010 May 31, 2011 10-K ↗	FY 2009 May 31, 2010 10-K ↗
Depreciation Expense (USD)	—	—	—	—	—	—	$488.00	$489.00	$763.00	$826.00	$1.30K	$2.05K	$2.30K	$2.59K	$3.19K	$9.37K	—
Net Income, GAAP (USD)	$-687.85K	$-921.98K	$-1.01M	$-2.38M	$-3.68M	—	$-1.06M	$-798.46K	$-1.21M	$-45.37K	$-1.27M	$-1.54M	$-1.47M	$1.10M	$-4.82M	$-11.52M	—
Operating Cash Flow (USD)	$-111.40K	$-241.16K	$-497.47K	$-690.13K	$-679.24K	—	$-986.76K	$-760.77K	$-880.17K	$-1.31M	$-1.58M	$-1.34M	$-1.50M	$-1.01M	$-2.40M	$-4.32M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 66 quarters

Mosaic ImmunoEngineering Inc.

Analytical Summary

17-Year Financial Trajectory

Health Breakdown

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare CPMV with peers